Dr. Andrew L. Pecora, MD, FACP, CPE, is a visionary hematologist-oncologist and healthcare innovator specializing in hematologic malignancies and cellular therapies. He is the Founder and Executive Chairman of COTA, Inc., and formerly served as Chief Innovation Officer at Hackensack Meridian Health. Dr. Pecora earned his medical degree from the University of Medicine and Dentistry of New Jersey, completed his residency at The New York Hospital-Cornell Medical Center, and fellowship in Hematology and Oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine, Hematology, and Oncology and is widely known for his leadership in healthcare analytics and real-world evidence in oncology.
Why they are a top doctor
Research papers · PubMed
42
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
7.1k
How often other doctors and researchers build on their work.
Background
Education
Medical school: University of Medicine & Dentistry of New Jersey Residency: New York Presbyterian Hospital (Weill Cornell) Fellowship: Memorial Sloan Kettering Cancer Center Board Certification: Internal Medicine, Hematology and Medical Oncology
Awards
BioNJ Dr. Sol J. Barer Award for Vision, Innovation & Leadership
ASCO Cancer Foundation Research Award
Gallo Award for Outstanding Cancer Research
Named among America’s Top Doctors and Who’s Who in the World